Tyndall Capital Partners

Latest statistics and disclosures from Tyndall Capital Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CYCN, and represent 100.00% of Tyndall Capital Partners's stock portfolio.
  • Added to shares of these 1 stock: CYCN.
  • Tyndall Capital Partners was a net buyer of stock by $56k.
  • Tyndall Capital Partners has $551k in assets under management (AUM), dropping by 9.04%.
  • Central Index Key (CIK): 0001219314

Tip: Access up to 7 years of quarterly data

Positions held by Tyndall Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Tyndall Capital Partners

Tyndall Capital Partners holds 1 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cyclerion Therapeutics (CYCN) 100.0 $551k +11% 164k 3.35
 View chart

Past Filings by Tyndall Capital Partners

SEC 13F filings are viewable for Tyndall Capital Partners going back to 2010

View all past filings